Evaluation of copper chaperone ATOX1 as prognostic biomarker in breast cancer. Blockhuys S, Brady DC, Wittung-Stafshede P. Breast Cancer 2020 Jan 2. pii: 10.1007/s12282-019-01044.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Blockhuys S, Brady DC, Wittung-Stafshede P. Evaluation of copper chaperone ATOX1 as prognostic biomarker in breast cancer. Breast Cancer 2020 Jan 2. pii: 10.1007/s12282-019-01044.
PMID: 31898157